ホーム › 膵臓がん › イリノイ州

イリノイ州における膵臓がんの臨床試験

イリノイ州内の拠点で、膵臓がんに関する31件の研究が参加者を募集しています。

イリノイ州内の都市

公式研究テキスト（英語）

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University of Chicago Hospital, Chicago

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

Illinois Cancer Specialists, Arlington Heights
City of Hope, Chicago
OSF Medical Center, Peoria

被験者募集中第3相

18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Northwestern University, Chicago

被験者募集中第1相

18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

被験者募集中第2相

18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Northwestern Medicine Chicago Proton Center, Warrenville

被験者募集中第2相

18歳以上 · 全性別 · 2026/09/29更新 · NCT02598349

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

University of Chicago Medical Center, Chicago

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07621718

Pancreatic Cancer Detection Consortium

OSF HealthCare, Peoria

被験者募集中観察研究健康なボランティア歓迎

18歳以上 · 全性別 · 2026/09/28更新 · NCT06388967

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

City of Hope Cancer Center-Chicago, Zion

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413

DESTINY-PANTUMOUR04

Research Site, Decatur

被験者募集中観察研究

18歳〜130歳 · 全性別 · 2026/09/25更新 · NCT07124000

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Cancer Care Specialists of Illinois, Decatur
Decatur Memorial Hospital, Decatur
Hope and Healing Clinical Research LLC, Hinsdale
他2件

被験者募集中第2/3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Investigative Site US079, Chicago
Investigative Site US030, Evanston
Investigative Site US005, Naperville
他1件

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073

Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts

OSF Saint Francis Medical Center, Peoria

被験者募集中観察研究

18歳以上 · 全性別 · 2026/09/21更新 · NCT06271291

CREO - Microwave Ablation Feasibility Study

Rush University Medical Center, Chicago

被験者募集中

18歳以上 · 全性別 · 2026/09/14更新 · NCT07817147

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
Carle BroMenn Outpatient Center, Bloomington
他52件

被験者募集中観察研究

50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

Memorial Hospital East, Shiloh

被験者募集中第1相

18歳以上 · 全性別 · 2026/09/03更新 · NCT05687123

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
Illinois CancerCare-Bloomington, Bloomington
他45件

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328

BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion

Northwestern University, Chicago

被験者募集中第1/2相

18歳以上 · 全性別 · 2026/08/25更新 · NCT07594626

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Chicago

被験者募集中第1/2相

18歳〜130歳 · 全性別 · 2026/08/12更新 · NCT05417594

Pancreatic Cancer Early Detection Consortium

Illinois CancerCare, Bloomington
University of Chicago Medicine, Chicago
NorthShore University HealthSystem, Evanston

被験者募集中観察研究健康なボランティア歓迎

18歳〜90歳 · 全性別 · 2026/07/22更新 · NCT04970056

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
Hope and Healing Cancer Services, Hinsdale
Orchard Healthcare Research, Skokie

被験者募集中第2相

18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177

Integrated Cancer Repository for Cancer Research

Rush-Copley Cancer Care Center, Aurora
Rush-Copley Healthcare Center, Yorkville

被験者募集中観察研究健康なボランティア歓迎

19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

University of Illinois Hospital and Health Sciences System /ID# 251750, Chicago
University of Chicago Medical Center /ID# 276271, Chicago

被験者募集中第1相

18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403

Evaluating the Prognostic Capability of ctDNA as a Biomarker in Pancreatic Cancer Patients Undergoing Neoadjuvant Chemotherapy

Northwestern Medicine Cancer Center Kishwaukee, DeKalb
Northwestern Medicine Cancer Center Delnor, Geneva
Northwestern Medicine Cancer Center Warrenville, Warrenville

被験者募集中観察研究

18歳以上 · 全性別 · 2026/06/18更新 · NCT04616131

Lidocaine Infusion in Pancreatic Cancer

University of Illnois at Chicago, Chicago

被験者募集中早期第1相

18歳以上 · 全性別 · 2026/06/15更新 · NCT04048278

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

Illinois CancerCare-Bloomington, Bloomington
Illinois CancerCare-Canton, Canton
Memorial Hospital of Carbondale, Carbondale
他29件

被験者募集中第3相

18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Northwestern University, Chicago
University of Illinois, Chicago

被験者募集中第3相

18歳以上 · 全性別 · 2026/03/31更新 · NCT06807437

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Ohio State University-Telemedicine, Champaign
Ohio State University-Telemedicine, Chicago
Ohio State University Telemedicine, Quincy

被験者募集中第2相

18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

OSF Saint Anthony's Health Center, Alton
Advocate Good Shepherd Hospital, Barrington
Illinois CancerCare-Bloomington, Bloomington
他40件

被験者募集中観察研究

18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Chicago

被験者募集中観察研究

全年齢 · 全性別 · 2025/10/28更新 · NCT03452774

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Advocate Christ Medical Center, Oak Lawn

被験者募集中第1/2相

18歳以上 · 全性別 · 2025/06/17更新 · NCT02843945

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors

Northwestern University, Chicago

被験者募集中第2相

18歳以上 · 全性別 · 2023/03/10更新 · NCT05733000

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。